Skip to main content

Table 2 Comparison of paediatric and adult nephrologist’s diagnostic practices for TMA

From: Differential diagnosis of thrombotic microangiopathy in nephrology

 

Response n (%)a

Paediatric nephrologist

n = 75

Adult nephrologist

n = 132

Apart from renal symptoms, which other organ manifestations would you consider clinically related to a diagnosis of TMA?

 Central nervous system

64 (96)

103 (84)

 Gastrointestinal

45 (67)

62 (50)

 Cardiovascular

36 (54)

52 (42)

 Pulmonary

30 (45)

22 (18)

What other conditions do you usually consider when assessing the differential diagnosis of TMA?

 Antiphospholipid syndrome

41 (60)

96 (79)

 Autoimmune haemolytic anaemia

42 (62)

96 (78)

 Clotting disorder

45 (66)

25 (21)

 Cobalamin metabolism disorder

18 (26)

43 (35)

 Drug induced

44 (65)

87 (71)

 HIV

15 (22)

38 (31)

 Infections

55 (81)

58 (48)

 Malignancy

22 (32)

78 (64)

 Pregnancy (HELLP syndrome)

15 (22)

86 (71)

 Scleroderma

9 (13)

48 (39)

 Sepsis

36 (53)

71 (58)

 Systemic lupus erythematosus

49 (72)

103 (84)

 Otherb

4 (7)

11 (9)

How extensive is your investigation of the patients’ family history?

 Ask the patient

21 (31)

75 (61)

 Investigate immediate family

19 (28)

28 (23)

 Complete a full family tree

28 (41)

19 (16)

Do you routinely perform genetic testing?

 Yes

46 (69)

49 (41)

 No

21 (31)

70 (59)

Are there any guidelines in place for the diagnosis of TMA at your hospital?

 Yes

49 (72)

51 (42)

 No

19 (28)

70 (58)

When the differential diagnosis of TMA was aHUS, what was the most challenging aspect of the diagnosis?c

 Absence of guidelines

2.1

2.5

 Delay in getting some laboratory results

3.7

3.4

 Absence of a single and reliable diagnostic test

3.6

3.5

 Heterogeneity of disease presentation

2.9

3.5

  1. aPercentage obtained from the number of responses received for individual questions
  2. bFifteen respondents also selected “other” considerations as free text; these included malignant hypertension (n = 6), viral infections (n = 3; H1N1, hantavirus and parvovirus), disseminated intravascular coagulation (n = 2), transplantation (n = 2), vasculitis (n = 2), aHUS (n = 1), HUS (n = 1), pre-eclampsia (n = 1), TTP (n = 1), and AKI of unknown aetiology (n = 1). Clinicians could include >1 answer in response to ‘Other’
  3. cClinicians were asked to grade their response from 1 (least challenging) to 5 (most challenging), data are presented as mean score. HELLP, haemolysis, elevated liver enzyme levels, and low platelet levels; HIV, human immune deficiency virus; TMA, thrombotic microangiopathy